English
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
36 resources available:
Clinical Challenges: Long-Term Management of Thyroid Eye Disease
Source:
www.medpagetoday.com
Nov 14, 2022
myBinder
Viridian Announces Positive Data From Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients With Thyroid Eye Disease (TED)
Source:
investors.viridiantherapeutics.com
Nov 14, 2022
myBinder
Tepezza Treatment Correlates to Improved Extraocular Muscle Size, Clinical Outcomes
Source:
www.healio.com
Oct 7, 2022
myBinder
A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
Source:
www.facebook.com
Sep 7, 2021
myBinder
Gut Microbes May Play Role in Graves ’ Disease Diagnosis, Thyroid Autoimmunity
Source:
www.healio.com
May 13, 2021
myBinder
Teprotumumab Improves Short and Long-Term Clinical Outcomes in Thyroid Eye Disease
Source:
www.healio.com
Apr 23, 2021
myBinderShow more
2 resources available:
Horizon Therapeutics plc Increases Peak U.S. Annual Net Sales Expectations for Key Growth Drivers
Source:
ir.horizontherapeutics.com
Jan 13, 2020
myBinder
Horizon Therapeutics plc Reports Strong Third-Quarter 2019 Results
Source:
ir.horizontherapeutics.com
Nov 6, 2019
myBinder4 resources available:
Clearing Hurdles: How Clinicians and Patients Can Create Their Own Winning Team
Source:
endocrinenews.endocrine.org
Sep 15, 2022
myBinder
Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to Focus on Thyroid Eye Disease
Source:
www.businesswire.com
Jun 28, 2021
myBinder
Expert Roundtable Discusses Clinical Impact of Thyroid Autoimmune Testing on Women’s Health
Source:
home.liebertpub.com
Oct 3, 2018
myBinder
Passing the Scientific Baton, From Father to Daughter
Source:
convergenceri.com
Nov 20, 2017
myBinder9 resources available:
Call for Applications – ASPECT Patient Engagement Program
Source:
www.onegravesvoice.com
Nov 11, 2022
myBinder
Immunovant Announces Two New Development Programs for Batoclimab
Source:
www.immunovant.com
Sep 7, 2022
myBinder
New Survey Finds Impact of TED on Quality of Life Continues Beyond Acute Into Chronic Phase
Source:
www.ophthalmologytimes.com
Feb 22, 2021
myBinder
New Topline TEPEZZA® (teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED)
Source:
www.businesswire.com
Jul 31, 2020
myBinderShow more
53 resources available:
The North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting
Source:
www.nanosweb.org
Mar 11, 2023
myBinder
Rare Disease Day at Nationwide Children’s Hospital
Source:
www.nationwidechildrens.org
Feb 28, 2023
myBinder
Show more
5 resources available:
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Brought to you by
Supported through an independent
educational grant by
